American Heart Journal
Volume 157, Issue 3 , Pages 436-441, March 2009

Study protocol for a randomized controlled trial: The feasibility and impact of cardiovascular absolute risk assessment in Australian general practice

  • Qing Wan, MBBS, MM, MPH

      Affiliations

    • Centre for Primary Health Care and Equity, School of Public Health and Community Medicine, University of New South Wales, Sydney, NSW, Australia
  • ,
  • Mark F. Harris, MBBS, MD, FRACGP

      Affiliations

    • Centre for Primary Health Care and Equity, School of Public Health and Community Medicine, University of New South Wales, Sydney, NSW, Australia
    • Corresponding Author InformationReprint requests: Mark Harris, MBBS, MD, FRACGP, Centre for Primary Health Care and Equity, School of Public Health and Community Medicine, University of New South Wales, NSW 2052, Australia.
  • ,
  • Nicholas Zwar, MBBS, PhD, FRACGP

      Affiliations

    • Centre for Primary Health Care and Equity, School of Public Health and Community Medicine, University of New South Wales, Sydney, NSW, Australia
  • ,
  • Terry Campbell, MD, DPhil, FRACP, FACC, FAHA

      Affiliations

    • Faculty of Medicine, University of New South Wales, NSW, Australia
  • ,
  • Anushka Patel, MBBS, SM, PhD, FRACP

      Affiliations

    • The George Institute For International Health, University of Sydney, Sydney, NSW, Australia
  • ,
  • Sanjyot Vagholkar, MBBS (Hons), MPH, FRACGP

      Affiliations

    • General Practice Unit, Fairfield Hospital, Fairfield, NSW, Australia
  • ,
  • Suzanne McKenzie, MBBS, MMedSci, GCULT, FRACGP

      Affiliations

    • School of Public Health and Community Medicine, University of New South Wales, Sydney, NSW, Australia
  • ,
  • Christine Walker, MA, PhD

      Affiliations

    • Chronic Illness Alliance, Camberwell, Victoria, Australia
  • ,
  • Elizabeth Denney-Wilson, BN, MPH, PhD

      Affiliations

    • Centre for Primary Health Care and Equity, School of Public Health and Community Medicine, University of New South Wales, Sydney, NSW, Australia
  • ,
  • on behalf of the ART study group

Received 4 August 2008; accepted 25 November 2008.

Background

Although cardiovascular absolute risk (CVAR) assessment has been recommended for use in Australian general practice for a number of years, there is continuing uncertainty about its implementation and impact. Our previous work has developed a multifaceted implementation model. This study aims to investigate both the feasibility of using this model and the impact of CVAR assessment and management on general practice clinical processes and patient care.

Study Design

This cluster randomized controlled trial will be conducted in general practices in Sydney, involving general practitioners (GPs), other practice staff, and patients aged 45 to 69 years without existing cardiovascular disease.

Methods

A total of 32 practices (40 GPs) and 1,320 patients will be recruited. Randomization will be conducted at the practice level. The intervention group of GPs will be trained to use a CVAR implementation model, whereas the control group of GPs will continue usual care. Study outcomes include clinical processes, patient risk, use of lifestyle intervention, and prescription of antihypertensive and lipid-lowering medications. Data will be collected and analyzed using mixed methods. Study outcomes before and after the intervention will be compared, and the 2 groups will also be compared after adjusting for baseline difference and clustering factors.

Discussion

This trial will be the first study in Australian general practice and one of few international studies to evaluate the impact of implementing CVAR assessment and management. Results of this study will help improve the primary prevention of cardiovascular disease and inform guidelines for clinical practice and the implementation of other health initiatives.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was funded by the Australian National Health and Medical Research Council.

 Registered clinical trial no.: ACTRN12608000387325.

PII: S0002-8703(08)01039-9

doi:10.1016/j.ahj.2008.11.016

American Heart Journal
Volume 157, Issue 3 , Pages 436-441, March 2009